Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections

Filip Jansåker, Niels Frimodt-Møller, Ingegerd Sjögren, Inge Jenny Dahl Knudsen

52 Citationer (Scopus)

Abstract

The prevalence of urinary tract infections (UTIs) caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is increasing and the therapeutic options are limited, especially in primary care. Recent indications have suggested pivmecillinam to be a suitable option. Here, we evaluated the clinical and bacteriological effects of pivmecillinam in UTIs caused by ESBL-producing Enterobacteriaceae.
OriginalsprogEngelsk
TidsskriftThe Journal of antimicrobial chemotherapy
Vol/bind69
Udgave nummer3
Sider (fra-til)769-772
Antal sider3
ISSN0305-7453
DOI
StatusUdgivet - mar. 2014

Fingeraftryk

Dyk ned i forskningsemnerne om 'Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections'. Sammen danner de et unikt fingeraftryk.

Citationsformater